Article
MiR-9-5p protects from kidney fibrosis by metabolic reprogramming
medRxiv · 2019 · Fierro-Fernandez, M.; Miguel, V.; Marquez-Exposito, L.; Nuevo-Tapioles, C.; Herrero, J. I.; Blanco-Ruiz, E.; Tituana, J.; Castillo, C.; Cannata, P.; Monsalve, M.; Ruiz-Ortega, M.; Ramos, R.; Lamas, S.
Key facts
| Title | MiR-9-5p protects from kidney fibrosis by metabolic reprogramming |
|---|---|
| First author | Fierro-Fernandez, M.; Miguel, V.; Marquez-Exposito, L.; Nuevo-Tapioles, C.; Herrero, J. I.; Blanco-Ruiz, E.; Tituana, J.; Castillo, C.; Cannata, P.; Monsalve, M.; Ruiz-Ortega, M.; Ramos, R.; Lamas, S. |
| Journal | medRxiv |
| Published | Jun 28, 2019 |
| DOI | 10.1101/667972 |
| Devices mentioned | K012371, K041074, K190495, K780428, K791373, K800781, K801244, K820613, K820614, K820942, K870938, K973350 and 2 more |
| Product codes mentioned | CFE, CFN, DDG, GKZ, JHI, JLW, JLX, KIS, KQP, DEW, GIA, LXG and 3 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1